These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15199294

  • 21. Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption.
    Schlemmer A, Hassager C.
    Eur J Endocrinol; 1999 Apr; 140(4):332-7. PubMed ID: 10097253
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Insights into the Role of Circadian Rhythms in Bone Metabolism: A Promising Intervention Target?
    Song C, Wang J, Kim B, Lu C, Zhang Z, Liu H, Kang H, Sun Y, Guan H, Fang Z, Li F.
    Biomed Res Int; 2018 Apr; 2018():9156478. PubMed ID: 30363685
    [Abstract] [Full Text] [Related]

  • 26. Parathyroid hormone: evolving therapeutic concepts.
    Lane NE.
    Curr Opin Rheumatol; 2004 Jul; 16(4):457-63. PubMed ID: 15201611
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological regulation of parathyroid hormone secretion.
    Nemeth EF.
    Curr Pharm Des; 2002 Jul; 8(23):2077-87. PubMed ID: 12171519
    [Abstract] [Full Text] [Related]

  • 28. Physiology of Parathyroid Hormone.
    Goltzman D.
    Endocrinol Metab Clin North Am; 2018 Dec; 47(4):743-758. PubMed ID: 30390810
    [Abstract] [Full Text] [Related]

  • 29. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.
    Sugimoto T, Kaji H, Nakaoka D, Yamauchi M, Yano S, Sugishita T, Baylink DJ, Mohan S, Chihara K.
    Eur J Endocrinol; 2002 Sep; 147(3):339-48. PubMed ID: 12213671
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels.
    Jubiz W, Canterbury JM, Reiss E, Tyler FH.
    J Clin Invest; 1972 Aug; 51(8):2040-6. PubMed ID: 5054463
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. New anabolic therapies in osteoporosis.
    Rubin MR, Bilezikian JP.
    Curr Opin Rheumatol; 2002 Jul; 14(4):433-40. PubMed ID: 12118181
    [Abstract] [Full Text] [Related]

  • 36. Parathyroid hormone - a bone anabolic and catabolic agent.
    Poole KE, Reeve J.
    Curr Opin Pharmacol; 2005 Dec; 5(6):612-7. PubMed ID: 16181808
    [Abstract] [Full Text] [Related]

  • 37. The bone-building action of the parathyroid hormone: implications for the treatment of osteoporosis.
    Whitfield JF, Morley P, Willick GE.
    Drugs Aging; 1999 Aug; 15(2):117-29. PubMed ID: 10495071
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
    [Abstract] [Full Text] [Related]

  • 40. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast.
    Fraser WD, Logue FC, Christie JP, Cameron DA, O'Reilly DS, Beastall GH.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):523-8. PubMed ID: 8187320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.